Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer

PURPOSE: Salvage second-line chemotherapy is usually recommended for patients with advanced epithelial ovarian cancer (AEOC) who develop progressive disease (PD) after neoadjuvant chemotherapy (NAC). Herein, we investigated the role of cytoreductive surgery (CRS) for such patients. MATERIALS AND MET...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Yonsei Med J
Autores principales: Shin, Wonkyo, Noh, Joseph J., Seo, Sang-Soo, Kang, Sokbom, Choi, Chel-Hun, Park, Sang-Yoon, Kim, Byoung-Gie, Lim, Myong Cheol
Formato: Artigo
Lenguaje:Inglês
Publicado: Yonsei University College of Medicine 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7593099/
https://ncbi.nlm.nih.gov/pubmed/33107236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2020.61.11.935
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares